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SummAry – Breast cancer accounted for 28% of all new cancers and 18% of female cancer de-
aths in europe in 2010. it is the most common type of cancer in women in Croatia, with an inciden-
ce rate of 56.9/100 000 in the year 2010, and the highest number of newly diagnosed women aged 
between 60 and 64. multiple factors are associated with an increased risk of breast cancer: advancing 
age, family history, exposure to endogenous and exogenous reproductive hormones, dietary factors, 
benign breast disease, and environmental factors. to assess demographic and clinicopathologic 
features of primary breast cancer, we retrospectively analyzed 870 patients treated in our institution 
between 1997 and 2010. Data were obtained from medical documentation and a printed questio-
nnaire regarding life habits. most of our patients presented with a breast lump and were self-diagno-
sed by breast examination. This fact highlights the need of regular breast self-examination, although 
it should also be taken into account that most of our patients did not attend regular mammography 
screening (only 31%). One of the most concerning facts is that the mean time from observing the 
first symptom to visiting a physician was 4 months. Previous studies have identified ignorance, fear 
and fatalistic attitudes, poor socioeconomic conditions, and illiteracy as important factors resulting 
in delay. Considering these facts, education and raising awareness about the disease in the general 
population is one of the key weapons for lowering breast cancer mortality.
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Introduction
Breast cancer is a major health problem for women 
throughout the world. in 2010, it was the most com-
mon type of cancer in europe in women, accounting 
for 28% of all new cancers and 18% of female cancer 
deaths1. The lowest mortality rates from breast cancer 
have been reported in Bulgaria, Portugal, Spain and 
Sweden, as well as norway (<20/100 000 females), 
while the highest rates are in Belgium and Denmark 
(approximately 30/100 000 females)2. in 2011, 11191 
men and 9319 women were diagnosed with invasive 
form of cancer in Croatia. Out of these 9319 wom-
en, 2094 had breast cancer, the most common type 
of cancer in women in Croatia, with a standardized 
incidence rate of 50.1/100 000, and the highest num-
ber of newly diagnosed women aged 60-64 in the 
year 2010. Data analysis from the Croatian national 
Cancer registry shows that the number of new breast 
cancer cases in the 1998-2008 period increased from 
1220 to 2472, and that the age-standardized inci-
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dence rate increased from 35.5 to 61.9/100 000. The 
number of deaths also increased from 670 to 902, but 
with no change in the age-standardized rate, which is 
approximately 18/100 0003. Considering the calendar 
period, there was a significantly increasing trend in 
the incidence, with estimated annual percent change 
(eAPC) of 2.6%, while it was -0.3% for mortality 
trend. The incidence increased in all age groups, most 
pronouncedly in women aged 60-69 in 2005, with 
eAPC of 14.2% for the 2005-2008 period. mortal-
ity rate decreased in younger women aged 30-49, but 
increased in women older than 60. in women aged 
50-59, mortality rate increased in the 1988-1999 pe-
riod, but decreased afterwards4. regarding breast 
cancer incidence and mortality, Croatia is among eu-
ropean countries with an intermediate incidence and 
mortality, with a comparable incidence increase in the 
1990-2002 period as well. This increase could be the 
result of lifestyle changes (a higher number of obese 
women, higher alcohol consumption, increased age at 
first delivery, use of hormonal therapy, and implemen-
tation of the national screening program, launched in 
2006).
Breast tumors are divided into invasive cancer (not 
otherwise specified (nOS)), special subtypes includ-
ing invasive lobular, tubular, cribriform, medullary, 
adenoid cystic, and many others. The most common 
form of breast cancer is invasive carcinoma (nOS), 
which accounts for 70%-80% of all cases5. lobular 
carcinoma is the second most common histologic type 
of breast cancer, and can be noninvasive or invasive. 
Other histologic types of breast cancer are Paget's dis-
ease, Paget's disease with intraductal carcinoma, Pag-
et's disease with invasive ductal carcinoma, undiffer-
entiated carcinoma, phyllodes tumor, angiosarcoma, 
and primary lymphoma. non-ductal cancers account 
for approximately 20%-30% of invasive carcinomas; 
at least 90% of a tumor should demonstrate defining 
histologic characteristics of a special type of cancer to 
be designated as this histologic type5.
multiple factors are associated with an increased 
risk of breast cancer: advancing age, positive family 
history, exposure to endogenous and exogenous re-
productive hormones, dietary factors, benign breast 
disease, and environmental factors6. The majority of 
these factors convey a small to moderate increase in 
the risk for any individual woman.
Patients and Methods
All patients with primary breast cancer treated in 
our institution between 1997 and 2010 were included 
in this study. A total of 870 patients were retrospec-
tively analyzed. Data were obtained from medical doc-
umentation and a printed questionnaire regarding life 
habits. All patients gave their consent to participate in 
the study. Demographic characteristics included age at 
the time of diagnosis, personal and family history of 
cancer, menstrual history and reproductive behavior, 
occupation, and type of diet. Questions also addressed 
perception of the lump and time to medical treatment 
(i.e. delay in treatment). Clinicopathologic characteris-
tics included tumor size, location, other features such as 
skin inflammation, retraction, fixation, and ulceration, 
then clinical stage, histologic type, lymph node metas-
tases (number and group of lymph nodes, extracapsular 
spread), and hormonal receptor- and her2/neu status. 
in a small percent of women, data were not available for 
some categories analyzed.
Results
eight hundred and seventy patients were analyzed. 
All patients were females. Demographic character-
istics, menstrual history and reproductive findings 
are shown in table 1. mean age was 69 years, most 
women were perimenopausal with an average length 
of fertile life of 35 years. Only 8% (n=71) of women 
were exposed to exogenous hormones (i.e. oral con-
traceptives), most of them for less than 5 years. Some 
15% of them were smokers, hardly any consumed al-
cohol (0.7%), and the preferred diet was mixed. Sixty-
three percent of women were employed, more than 
half with a sedentary occupation. Fifteen percent of 
women were nulliparous, the mean number of chil-
dren per woman was 1.6, and only 5% gave birth to 
their first child after the age of 35. Thirty percent had 
benign breast disease prior to breast cancer diagnosis. 
mean age at diagnosis was 59 years, and only 31% of 
women had regular mammography screening prior to 
the breast cancer diagnosis.
Family history for breast and/or ovarian cancer 
was positive in 19% of patients, mostly for breast can-
cer (96%). Six percent of women had positive personal 
history, i.e. they had been previously treated for some 
other malignancy (table 2).
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most women had palpable tumor presenting as 
a breast lump, discovered in the majority of cases by 
patients themselves. in one-third of patients, breast 
lump was found by a physician, and in less than 1% it 




          unemployed
          employed
          not analyzed
Occupation
          Sedentary
          Active          
281   (32.3%)
552   (63.4%)
37
371   (67.2%)
181   (32.8%)
Constitution
          Skinny
          medium
          Fat
          not analyzed
17     (2%)
313   (36%)
126   (14.5%)
414
Breast size
          Small
          medium
          Voluminous
          not analyzed
101   (11.6%)
407   (46.8%)
347   (39.9%)
15
Diet
          meat
          mixed
          Fat rich
          Vegetarian
          not analyzed
23     (2.6%)
821   (94.4%)
10     (1.1)
2       (0.2%)    
14
Smoking
          yes
          no
          not analyzed
127   (14.6%)
742   (85.3%)
1 
Alcohol 
         yes
          no
          not analyzed
6       (0.7%)
863   (99.2%)
1 
use of oral contraceptives 
        <5 years
         ≥5 years 
         no history of use
44     (5.1%)
27     (3.1%)
799   (91.8%)
menstrual status
         Fertile
         Perimenopause
         Postmenopause
         not analyzed
68     (7.8%)
736   (84.6%)
64     (7.4%)
2
Table 2. Personal and family history (N=870)
Category number (%)
Positive family history for breast 
and/or ovarian cancer
          yes
               Breast cancer
               Ovarian cancer
          no
168      (19.3%)
162      (96.4%)
 6         (3.6%)
702      (80.7%)
Positive personal history
         yes
          no
          not analyzed
50        (5.7%)
819      (94.1%)
1
Table 3. Diagnosis (N=870)
Category number (%)
Palpable tumor
      no
              uS, mammography
              Other
      yes
              Self-diagnosed
              Physician
       not analyzed
13       (1.5%)
3         (23.1%)
10       (76.9%)
856     (98.4%)
577     (67.4%)
279     (32.6%)
1
mean time from self-diagnosis 




was an accidental finding on ultrasound or mammog-
raphy. Average time from self-diagnosis to first visit to 
a physician was around 4 months (table 3).
in 95% of women, there were no physical findings 
other than breast lump. in the rest, the most common 
physical finding was skin ulceration. Primary tumor 
was mostly localized in the upper lateral quadrant, 
with a mean size of 2.5 cm. The most common histol-
ogy was invasive carcinoma (nOS), of which 66% of 
tumors were moderately, 21% poorly, and 13% well 
differentiated. Cancer cells were er and Pr positive 
in 62% and 55% of women, respectively. Only 8% of 
women had her2/neu positive tumors, but in more 
than half of women her2/neu receptor status was 
not analyzed (table 4). The mean number of evacu-
ated lymph nodes was 11.32, mean number of posi-
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tive lymph nodes 2.64, and extracapsular spread was 
found in 6% of patients. The mean size of the largest 
node was 1.64 cm. At the time of diagnosis, distant 
metastases were found in only 32 (3.7%) women, with 
bones being the most common site of distant spread 
(table 5).




     upper lateral quadrant
     lower lateral quadrant
     upper medial quadrant
     lower medial quadrant
     Areolar
     multilobular
     multicentric
     not analyzed
457     (52.5%)
78       (9%)
86       (9.9%)
35       (4%)
97       (11.1%)
8         (0.9%)
63       (7.2%)
46                       
histology
     not otherwise specified (nOS)
     lobular
     inflamed
     Papillary
     tubular
     medullary
     mucinous (gelatinous)
     Cribriform
     Adenocarcinoma
     Paget’s disease
     neuroendocrine
     histiocytoma
     Sarcoma
     Squamous cell carcinoma
     not analyzed
742   (85.3%)
55     (6.3%)
4       (0.5%)
7       (0.8%)
9       (1%)
14     (1.6%)
14     (1.6%)
4       (0.5%)
3       (0.3%)
4       (0.5%)
3       (0.3%)
1       (0.1%)
1       (0.1%)
4       (0.5%)     
5             
receptor status
     estrogen receptors (er)
          Positive
          negative
          not analyzed
     Progesterone receptors (Pr)
          Positive
          negative
          not analyzed
her2/neu receptors
          Positive
          negative
          not analyzed
541   (62.2%)
215   (24.7%)
114
477   (54.8%)
212   (24.4%)
181
72      (8.3%)
328    (37.7%)
470
Table 5. Distant metastases (N=870)
Distant metastases at 
the time of diagnosis
     no
     yes
           Bones
           lung
           liver
           Brain
           Skin
           lymph nodes
           multiple
           Other
     not analyzed
837   (96.2%)
32     (3.7%)
18     (56.3%)
0        
4       (12.5%)
0
3       (9.4%)
2       (6.3%)
3       (9.4%)
2       (6.3%)
1 
Table 6. Treatment (N=870)
Category number (%)
Surgery
     radical
     Breast conserving
     inoperable
     not analyzed
407   (46.8%)
460   (52.9%)
1       (0.1%)                       
2
radiotherapy
     Primary
     Adjuvant
     none
     not analyzed
2        (0.2%)                         
812    (93.3%)
50      (5.7%)
6                       
Chemotherapy regimens
Applied - Adjuvant
          CmF
          FeC 
          FAC
          AC 




          CmF
          FeC
          FAC
not applied
not analyzed
392    (45.1%)
54      (13.8%)
259    (66.1%)
33      (8.4%)
44      (11.2%)
2        (0.5%)              
477    (54.8%)
1 
13      (1.5%)
3        (23.1%)
9        (69.2%)
1        (7.7%)
856    (98.4%)
1
hormonal therapy
     no
     yes (tamoxifen)
     not analyzed
405    (46.6%)
463    (53.2%)
2               
CmF = cyclophosphamide, methotrexate and 5-fluorouracil; 
FeC = 5-fluorouracil, epirubicin and cyclophosphamide; FAC 
= 5-fluorouracil, doxorubicin and cyclophosphamide; AC = 
doxorubicin and cyclophosphamide; eC = epirubicin and 
cyclophosphamide 
Acta Clin Croat,  Vol. 54,   No. 3,  2015 299
Daniela Žitnjak et al. Characteristics of breast cancer: a single institution experience
The most common surgical procedure was breast 
conserving therapy (53%), and 93% of women re-
ceived adjuvant radiotherapy. Adjuvant chemotherapy 
was administered in 45% of patients, most commonly 
FeC (5-fluorouracil, epirubicin and cyclophosph-
amide) regimen. more than half of patients (53%) 
were treated with hormonal therapy as well (table 6).
Discussion
Our analysis showed the mean age at diagnosis to 
be 69, which is in accordance with the results from 
other european countries2. As in many other malig-
nant tumors, age is an important and independent risk 
factor for breast cancer as well6. less than 2% of our 
patients were younger than 35, and the youngest one 
was 25 years old. 
Considering lifestyle factors, physical activity 
reduces the risk of breast cancer by approximately 
25%7. most of our patients had sedentary occupation 
and spent most of their daily hours inactive, so there 
was no protective effect that any kind of regular, daily 
physical activity could ensure. regarding other habits, 
it is known from the literature that there appears to be 
a positive association between alcohol consumption 
and breast cancer risk, with the risk increasing linearly 
with the amount of alcohol consumed8. Surprisingly, 
only a very small percent of our study patients declared 
themselves as smokers (15%) and alcohol consumers 
(0.7%). Since these numbers are not even close to 
the percentage of smokers and especially alcohol 
consumers in the Croatian general population, it is 
likely that most women did not want to admit their 
habit, probably because of shame, judgment, fear, or 
some other reasons. Obesity is also associated with an 
increased risk of both breast cancer development in 
postmenopausal women and increased breast cancer 
mortality6. According to one survey9, the prevalence 
of obesity in Croatian people, both men and women, 
was 11% and of overweight 46%, with the critical age 
at getting overweight from 35 to 49 years. Only 14% 
of our patients were overweight and obese, and had 
an increased risk of breast cancer as a result of their 
adiposity.
The observation that there is large international 
variation in breast cancer incidence, with countries 
with high fat diets having higher rates of breast cancer 
than those with diets lower in fat, suggests that high 
fat intake might be associated with an increased 
breast cancer risk. however, pooled analysis of seven 
prospective epidemiological studies failed to identify 
an association between fat intake and breast cancer 
risk in adult women in developed countries10. in our 
analysis, most women practiced balanced diet with 
adequate amounts of all nutrients, and only 1.1% 
consumed fat rich diet. According to the literature, 
there may be a moderate protective effect of high 
vegetable consumption, but results for fruit, fiber and 
meat consumption are inconclusive.
epidemiological studies have identified a number 
of breast cancer risk factors associated with increased 
exposure to endogenous estrogens11. early age at 
menarche, nulliparity, late age at first full-term 
pregnancy, and late age at menopause increase the 
risk of developing breast cancer. in postmenopausal 
women, obesity and postmenopausal hormone 
replacement therapy, both of which are positively 
correlated with plasma estrogen levels and plasma 
estradiol levels, are associated with an increased 
breast cancer risk12,13. Age at menarche and regular 
ovulatory cycles are strongly linked to breast cancer 
risk6. earlier age at menarche is associated with an 
increased risk of breast cancer; there appears to be a 
20% decrease in breast cancer risk for each year that 
menarche is delayed. in our analysis, the mean age 
at menarche was 13.7 years, which is according to 
the literature considered to be similar to the general 
population (13.3 years)14.  Additionally, late onset 
of menarche results in a delay in regular ovulatory 
cycles. From these data, it seems that total duration 
of exposure to endogenous estrogen is an important 
factor in breast cancer risk. mean age at menopause 
in our patients was 48.8 years, which taken together 
with mean age at menarche resulted in the mean dura-
tion of fertile life of 34.7 years, which is similar to the 
general population. Based on epidemiological studies, 
women whose first full-term pregnancy occurs after 
age 30 have a two- to fivefold increase in breast cancer 
risk in comparison to women who have first full-term 
pregnancy before age 1815. Our data showed that 5% 
of women gave birth to their first child after the age of 
35. nulliparous women are also at an increased risk of 
developing breast cancer, with a relative risk of about 
1.4. most of our patients were multiparous, while 15% 
of women were nulliparous.
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Positive family history was observed in 19% of 
patients; when analyzed for breast and ovarian can-
cer family history, 96% of these patients had a rela-
tive with breast cancer. The impact of family history 
as a risk factor depends on the number of relatives 
with breast cancer, the exact relationship, the age at 
diagnosis, and the number of unaffected relatives. 
north American investigators with special interest 
in familial breast cancer have described positive fam-
ily history (first- or second-degree relatives) in up to 
one-third of patients16. Only 5% to 10% of women 
with BrCA1 and BrCA2 gene mutations have a true 
hereditary predisposition17.
most of our patients presented with a breast lump 
and were self-diagnosed by breast examination. This 
fact highlights the need of regular breast self-exami-
nation, although it should also be taken into account 
that most of our patients did not attend regular mam-
mography screening. if so, greater part of these tumors 
would have probably been found and diagnosed at an 
earlier stage of the disease. in contrast to developed 
countries, where a high percent of women after the 
age of 50 have yearly mammograms18-20, in our study 
only 31% of women attended regular mammography 
screening prior to breast cancer diagnosis. hopefully, 
these unfavorable results will change since the nation-
al screening program for breast cancer was introduced 
in 2006. One of the most concerning facts is that the 
mean time from observing the first symptom to visit-
ing a physician was 4 months. Previous studies have 
identified ignorance, fear and fatalistic attitudes, poor 
socioeconomic conditions, and illiteracy as important 
factors resulting in delay21-23. in this analysis, infor-
mation about the reasons for delayed seeking medical 
advice was not discussed in detail with patients, but 
one can conclude that it was a matter of dissimulation 
and fear. Considering these facts, education and rais-
ing awareness about the disease in the general popu-
lation is one of the key weapons for lowering breast 
cancer mortality. Failure to visit a physician promptly 
has surely led to a higher disease stage at diagnosis in 
some patients; more than one-third were diagnosed 
with locally advanced disease, i.e. metastases in axil-
lary lymph nodes. Fortunately, only 4% had distant 
metastases at the time of diagnosis. The mean number 
of evacuated lymph nodes was 11.32 and the mean 
number of positive lymph nodes was 2.64. extraca-
psular spread was found in only 6% of patients. The 
most common histology was ductal carcinoma (86%), 
whereas no unusual incidence was recorded for other 
types. Cancer was most often localized in the upper 
lateral quadrant of the breast. less than one-third of 
patients had tumor cells negative for hormonal recep-
tors. Only 8% had positive her2 tumors, but our 
analysis was insufficient here because information 
about her2/neu receptor status was unknown in 
54% of patients; in a small percent of these patients, 
supplementation of histopathologic diagnosis was not 
available at the time of recruitment, but in the major-
ity of them probably not performed due to the fact 
that immunohistochemical analysis for her2/neu 
receptor was not a routine procedure in Croatia until 
2003. Data regarding Ki-67 proliferation index were 
not available.
The most common surgical procedure performed 
on these patients was breast conservation followed 
by adjuvant radiotherapy. however, a significant per-
cent of women (47%) underwent radical mastectomy. 
When analyzed chronologically, radical mastectomy 
was the most common type of surgery until 2002 and 
most of these women were operated in that period. 
After 2002, breast conserving surgery has become 
a standard. ninety-four percent of patients received 
adjuvant radiotherapy, which can be explained by the 
above mentioned locally more advanced disease, as 
well as the type of surgery. Considering chemother-
apy, it was applied in 405 (46.6%, mostly in adjuvant 
setting) women and consisted mostly of 5-fluoroura-
cil, epirubicin and cyclophosphamide (FeC regimen), 
most often used in other countries as well. 
in conclusion, our data show that patients with 
breast cancer treated in our institution from 1997 to 
2010, when compared to their european counterparts, 
more often presented with locally advanced disease at 
the time of diagnosis, with t2 primary tumor and n2 
lymph node stage. There was no apparent change in 
lifestyle throughout the years that would significantly 
increase the risk of breast cancer (smoking, alcohol, 
obesity), but the number of sedentary professions was 
higher in the last decade. Considering surgical and 
oncologic treatment, our patients were treated accord-
ing to current standards. The most important infor-
mation obtained was the one about the time from self-
diagnosis to seeking physician’s advice, which was as 
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long as 4 months. it is a major social and healthcare 
problem, and reduces the possibility of complete re-
covery. in order to improve the outcome of these pa-
tients, it is essential to understand the reasons behind 
delayed presentation and to take appropriate remedial 
measures. more intensive health promotion and edu-
cation is needed. There is a great need to additionally 
increase public awareness and make the most of the 
national screening program. 
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Sažetak
DemOgrAFSKA i KliniČKO-PAtOlOŠKA OBilJeŽJA BOleSniCA S PrimArnim rAKOm DOJKe 
liJeČenih u rAZDOBlJu OD 1997. DO 2010. gODine: iSKuStVO JeDne KliniKe
D. Žitnjak, Ž. Soldić, D. Kust, A. Bolanča i Z. Kusić
u europskoj populaciji rak dojke činio je 2010. godine 28% svih novodijagnosticiranih zloćudnih tumora te bio uzro-
kom smrti u 18% žena oboljelih od raka. Prvi je po učestalosti zloćudni tumor u žena u hrvatskoj, s incidencijom od 
56,9/100.000 (2010. godine), a najveći broj bolesnica dijagnosticira se u dobi između 60 i 64 godine. rizični čimbenici 
za rak dojke su višestruki: dob, pozitivna obiteljska anamneza, izloženost endogenim i egzogenim hormonima, prehrana, 
dobroćudna bolest dojke te okolišni čimbenici. radi procjene demografskih i kliničko-patoloških značajka primarnog raka 
dojke retrospektivno smo analizirali 870 bolesnica koje su liječene u našoj ustanovi između 1997. i 2010. godine. Podaci su 
prikupljeni iz medicinske dokumentacije te formuliranog upitnika koji se odnosio na životne navike. u većine bolesnica se 
bolest prezentirala kao čvor u dojci te su bolest dijagnosticirale same. Ova činjenica naglašava potrebu redovitog samopre-
gleda, iako također treba uzeti u obzir činjenicu da je tek manji broj bolesnica redovito pohađao kontrolne mamografske 
preglede (31%). Zabrinjava podatak da je prosječno vrijeme od prvog simptoma bolesti do javljanja liječniku bilo čak 4 
mjeseca. Prema ranijim studijama najvažniji razlozi odgode javljanja liječniku su neznanje, strah i fatalistički odnos prema 
bolesti, niži socioekonomski status te nepismenost. u skladu s dobivenim rezultatima, izobrazba i podizanje svijesti o 
bolesti u općoj populaciji među ključnim su metodama za snižavanje smrtnosti od raka dojke.
Ključne riječi: Dojka, tumori – patologija; Dojka, tumori – epidemiologija; Dojka, tumori – dijagnostika; Čimbenici rizika; 
Rano otkrivanje tumora; Bolesnik, edukacija kao tema 
